216 related articles for article (PubMed ID: 35277785)
1. A review on the genetic polymorphisms and susceptibility of cancer patients in Bangladesh.
Babu G; Bin Islam S; Khan MA
Mol Biol Rep; 2022 Jul; 49(7):6725-6739. PubMed ID: 35277785
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in XRCC1, ERCC2, and ERCC3 DNA repair genes, CYP1A1 xenobiotic metabolism gene, and tobacco are associated with bladder cancer susceptibility in Tunisian population.
Feki-Tounsi M; Khlifi R; Louati I; Fourati M; Mhiri MN; Hamza-Chaffai A; Rebai A
Environ Sci Pollut Res Int; 2017 Oct; 24(28):22476-22484. PubMed ID: 28803404
[TBL] [Abstract][Full Text] [Related]
3. Smoking and polymorphisms in xenobiotic metabolism and DNA repair genes are additive risk factors affecting bladder cancer in Northern Tunisia.
Rouissi K; Ouerhani S; Hamrita B; Bougatef K; Marrakchi R; Cherif M; Ben Slama MR; Bouzouita M; Chebil M; Ben Ammar Elgaaied A
Pathol Oncol Res; 2011 Dec; 17(4):879-86. PubMed ID: 21647780
[TBL] [Abstract][Full Text] [Related]
4. Correlation between gene polymorphisms of CYP1A1, GSTP1, ERCC2, XRCC1, and XRCC3 and susceptibility to lung cancer.
Liu HX; Li J; Ye BG
Genet Mol Res; 2016 Nov; 15(4):. PubMed ID: 27819744
[TBL] [Abstract][Full Text] [Related]
5. ERCC2 Lys751Gln rs13181 and XRCC2 Arg188His rs3218536 Gene Polymorphisms Contribute to Subsceptibility of Colon, Gastric, HCC, Lung And Prostate Cancer.
Balkan E; Bilici M; Gundogdu B; Aksungur N; Kara A; Yasar E; Dogan H; Ozturk G
J BUON; 2020; 25(1):574-581. PubMed ID: 32277685
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms in CDH1 and Exo1 genes elevate the prostate cancer risk in Bangladeshi population.
Imtiaz H; Afroz S; Hossain MA; Bellah SF; Rahman MM; Kadir MS; Sultana R; Mazid MA; Rahman MM
Tumour Biol; 2019 Mar; 41(3):1010428319830837. PubMed ID: 30880589
[TBL] [Abstract][Full Text] [Related]
7. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
[TBL] [Abstract][Full Text] [Related]
8. TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients.
Nairuz T; Rahman M; Bushra MU; Kabir Y
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2091-2098. PubMed ID: 32711437
[TBL] [Abstract][Full Text] [Related]
9. Role of DNA repair and cell cycle control genes in ovarian cancer susceptibility.
Mohamed FZ; Hussien YM; AlBakry MM; Mohamed RH; Said NM
Mol Biol Rep; 2013 May; 40(5):3757-68. PubMed ID: 23277402
[TBL] [Abstract][Full Text] [Related]
10. Influence of polymorphisms in xenobiotic-metabolizing genes and DNA-repair genes on diepoxybutane-induced SCE frequency.
Laczmanska I; Gil J; Karpinski P; Stembalska A; Kozlowska J; Busza H; Trusewicz A; Pesz K; Ramsey D; Schlade-Bartusiak K; Blin N; Sasiadek MM
Environ Mol Mutagen; 2006 Dec; 47(9):666-73. PubMed ID: 17078101
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer risk in relation to nicotinic acetylcholine receptor, CYP2A6 and CYP1A1 genotypes in the Bangladeshi population.
Islam MS; Ahmed MU; Sayeed MS; Maruf AA; Mostofa AG; Hussain SM; Kabir Y; Daly AK; Hasnat A
Clin Chim Acta; 2013 Feb; 416():11-9. PubMed ID: 23178447
[TBL] [Abstract][Full Text] [Related]
12. Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer.
Zhao F; Shang Y; Zeng C; Gao D; Li K
Int J Clin Exp Pathol; 2015; 8(9):11579-86. PubMed ID: 26617894
[TBL] [Abstract][Full Text] [Related]
13. Influence of CYP1A1, CYP2E1, GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility: results from a case-control study in Rio de Janeiro.
Marques CF; Koifman S; Koifman RJ; Boffetta P; Brennan P; Hatagima A
Oral Oncol; 2006 Jul; 42(6):632-7. PubMed ID: 16488179
[TBL] [Abstract][Full Text] [Related]
14. Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population.
Parvin S; Islam MS; Al-Mamun MM; Islam MS; Ahmed MU; Kabir ER; Hasnat A
Breast Cancer; 2017 Mar; 24(2):229-237. PubMed ID: 27068824
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between genetic polymorphisms of metabolizing enzymes and prostate cancer].
Gao JP; Huang YD; Yang GZ; Yang YQ
Zhonghua Nan Ke Xue; 2003 Feb; 9(1):32-5. PubMed ID: 12680328
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.
López-Cima MF; González-Arriaga P; García-Castro L; Pascual T; Marrón MG; Puente XS; Tardón A
BMC Cancer; 2007 Aug; 7():162. PubMed ID: 17705814
[TBL] [Abstract][Full Text] [Related]
17. Effect of Genetic Polymorphisms and Long-Term Tobacco Exposure on the Risk of Breast Cancer.
Verde Z; Santiago C; Chicharro LM; Reinoso-Barbero L; Tejerina A; Bandrés F; Gómez-Gallego F
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27754415
[TBL] [Abstract][Full Text] [Related]
18. Inter-ethnic differences in genetic polymorphisms of xenobiotic-metabolizing enzymes (CYP1A1, CYP2D6, NAT1 and NAT2) in healthy populations: correlation with the functional in silico prediction.
Khlifi R; Ben Salah G; Chakroun A; Hamza-Chaffai A; Rebai A
Mol Biol Rep; 2014 Sep; 41(9):5735-43. PubMed ID: 24934312
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility.
Mota P; Silva HC; Soares MJ; Pego A; Loureiro M; Cordeiro CR; Regateiro FJ
J Cancer Res Clin Oncol; 2015 May; 141(5):851-60. PubMed ID: 25388590
[TBL] [Abstract][Full Text] [Related]
20. Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer.
Damaraju S; Murray D; Dufour J; Carandang D; Myrehaug S; Fallone G; Field C; Greiner R; Hanson J; Cass CE; Parliament M
Clin Cancer Res; 2006 Apr; 12(8):2545-54. PubMed ID: 16638864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
